Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality

    26 Citationer (Scopus)

    Abstract

    Elevated levels of lipoprotein(a) are associated with an increased risk of myocardial infarction. Our study aimed to test whether genetic data are consistent with this association being causal. Accordingly, we developed a high-throughput realtime PCR assay to genotype for the lipoprotein(a) kringle IV type 2 (KIV-2) repeat polymorphism in the LPA gene in > 40,000 individuals. The LPA KIV-2 genotype associated with plasma levels of lipoprotein(a) (trend p < 0.001), and the LPA KIV-2 genotype associated with risk of myocardial infarction (trend p < 0.001 to 0.03) in a manner consistent with its effect on plasma levels of lipoprotein(a). The association of LPA KIV-2 genotypes raising plasma levels of lipoprotein(a) with increased risk of myocardial infarction strongly supports a causal association of lipoprotein(a) with risk of myocardial infarction.

    OriginalsprogEngelsk
    TidsskriftScandinavian Journal of Clinical & Laboratory Investigation
    Vol/bind71
    Udgave nummer2
    Sider (fra-til)87-93
    Antal sider7
    ISSN0036-5513
    DOI
    StatusUdgivet - apr. 2011

    Fingeraftryk

    Dyk ned i forskningsemnerne om 'Lipoprotein(a) and risk of myocardial infarction--genetic epidemiologic evidence of causality'. Sammen danner de et unikt fingeraftryk.

    Citationsformater